Measurement Properties of 4 Patient-Reported Outcome Measures to Assess Sleep Disturbance in Adults With Atopic Dermatitis.
Journal
Dermatitis : contact, atopic, occupational, drug
ISSN: 2162-5220
Titre abrégé: Dermatitis
Pays: United States
ID NLM: 101207335
Informations de publication
Date de publication:
Historique:
entrez:
18
9
2020
pubmed:
19
9
2020
medline:
23
7
2021
Statut:
ppublish
Résumé
The ideal patient-reported outcome measure to assess sleep disturbance in atopic dermatitis (AD) has not been determined. We sought to determine the measurement properties of the Patient-Reported Outcomes Measurement Information System (PROMIS) Itch Questionnaire Mood and Sleep (PIQ-MS), Sleep Disturbance (SD), Sleep-Related Impairment (SRI), and Epworth Sleepiness Scale (ESS) in adults with AD. A prospective dermatology practice-based study was performed using questionnaires and evaluation by a dermatologist (n=611). PIQ-MS, PROMIS SD, SRI, and ESS had good convergent validity with intensity and frequency of sleep disturbance, Patient-Oriented Eczema Measure, Eczema Area and Severity Index, total and objective-Scoring AD, Numerical Rating Scale of worst-itch and average-itch, and Dermatology Life Quality Index. PIQ-MS had significantly better correlations with other severity measures than the other sleep measures (Fisher z-scores, P≤0.007). PIQ-MS, and to lesser extent PROMIS SD, PROMIS SRI and ESS had good discriminant validity. All four sleep assessments showed fair responsiveness to change of severity of sleep-disturbance, AD and itch. PIQ-MS had the best reliability. PIQ-MS, PROMIS SD, SRI and ESS showed good internal consistency and were feasible for use in clinical practice. PIQ-MS, followed by PROMIS SD, had the best construct validity and reliability in adult AD.
Sections du résumé
BACKGROUND
BACKGROUND
The ideal patient-reported outcome measure to assess sleep disturbance in atopic dermatitis (AD) has not been determined.
OBJECTIVE
OBJECTIVE
We sought to determine the measurement properties of the Patient-Reported Outcomes Measurement Information System (PROMIS) Itch Questionnaire Mood and Sleep (PIQ-MS), Sleep Disturbance (SD), Sleep-Related Impairment (SRI), and Epworth Sleepiness Scale (ESS) in adults with AD.
METHODS
METHODS
A prospective dermatology practice-based study was performed using questionnaires and evaluation by a dermatologist (n=611).
RESULTS
RESULTS
PIQ-MS, PROMIS SD, SRI, and ESS had good convergent validity with intensity and frequency of sleep disturbance, Patient-Oriented Eczema Measure, Eczema Area and Severity Index, total and objective-Scoring AD, Numerical Rating Scale of worst-itch and average-itch, and Dermatology Life Quality Index. PIQ-MS had significantly better correlations with other severity measures than the other sleep measures (Fisher z-scores, P≤0.007). PIQ-MS, and to lesser extent PROMIS SD, PROMIS SRI and ESS had good discriminant validity. All four sleep assessments showed fair responsiveness to change of severity of sleep-disturbance, AD and itch. PIQ-MS had the best reliability. PIQ-MS, PROMIS SD, SRI and ESS showed good internal consistency and were feasible for use in clinical practice.
CONCLUSIONS
CONCLUSIONS
PIQ-MS, followed by PROMIS SD, had the best construct validity and reliability in adult AD.
Identifiants
pubmed: 32947460
doi: 10.1097/DER.0000000000000625
pii: 01206501-202009000-00009
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM